Serum/plasma homocysteine levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis
暂无分享,去创建一个
D. Ye | Xiao-mei Li | H. Pan | De-guang Wang | Bao-Zhu Li | Qin Zhang | N. B. Sam
[1] Douglas G. Altman,et al. Analysing data and undertaking meta‐analyses , 2019, Cochrane Handbook for Systematic Reviews of Interventions.
[2] Mh Megallaa,et al. THU0282 Homocysteine: any role in peripheral vascular disease in systemic lupus erythematosus (SLE) patients? , 2017 .
[3] A. Larsson,et al. Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls , 2017, PloS one.
[4] N. Khairy,et al. Atherosclerosis biomarkers in female systemic lupus erythematosus patients with and without cardiovascular diseases , 2017 .
[5] E. Antiga,et al. Homocysteine serum levels are increased and correlate with disease severity in patients with lupus erythematosus. , 2016, Clinical and experimental rheumatology.
[6] Z. Mo,et al. Serum Homocysteine Concentration Is Significantly Associated with Inflammatory/Immune Factors , 2015, PloS one.
[7] J. Sabio,et al. Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus , 2015, Lupus.
[8] J. Sabio,et al. Relationship Between Homocysteine Levels and Hypertension in Systemic Lupus Erythematosus , 2014, Arthritis care & research.
[9] A. Dyer,et al. Risk Factors in the Progression of Subclinical Atherosclerosis in Women With Systemic Lupus Erythematosus , 2014, Arthritis care & research.
[10] Jiming Liu,et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.
[11] Xiaolan Huang,et al. Hypomethylation of long interspersed nucleotide element‐1 in peripheral mononuclear cells of juvenile systemic lupus erythematosus patients in China , 2014, International journal of rheumatic diseases.
[12] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[13] V. Kutala,et al. Association of genetic variants of xenobiotic metabolic pathway with systemic lupus erythematosus. , 2013, Indian journal of biochemistry & biophysics.
[14] V. D’Almeida,et al. Dyslipidemia in Pediatric Systemic Lupus Erythematosus: The Relationship with Disease Activity and Plasma Homocysteine and Cysteine Concentrations , 2013, Annals of Nutrition and Metabolism.
[15] B. Jallal,et al. Biomarkers for systemic lupus erythematosus , 2012, International journal of rheumatic diseases.
[16] S. Tyagi,et al. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. , 2011, Antioxidants & redox signaling.
[17] P. Raggi,et al. Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis , 2011, Arthritis care & research.
[18] A. Stang. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.
[19] S. Tyagi,et al. Homocysteine to Hydrogen Sulfide or Hypertension , 2010, Cell Biochemistry and Biophysics.
[20] Y. Shoenfeld,et al. The geoepidemiology of systemic lupus erythematosus. , 2010, Autoimmunity reviews.
[21] C. Lacabanne,et al. Changes in the physical structure and chain dynamics of elastin network in homocysteine-cultured arteries. , 2009, Journal of biomedical materials research. Part A.
[22] D. Moher,et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.
[23] Jong Sun Park,et al. Pulse wave velocity in young premenopausal women with systemic lupus erythematosus , 2009 .
[24] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.
[25] A. Cucchiara,et al. Functional Polymorphisms of Folate-Metabolizing Enzymes in Relation to Homocysteine Concentrations in Systemic Lupus Erythematosus , 2008, The Journal of Rheumatology.
[26] Douglas G. Altman,et al. Chapter 9: Analysing Data and Undertaking Meta-Analyses , 2008 .
[27] A. Dyer,et al. Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus. , 2008, The Journal of rheumatology.
[28] Michael H Weisman,et al. New therapies for treatment of rheumatoid arthritis , 2007, The Lancet.
[29] Xian Wang,et al. Immunoregulatory effects of homocysteine on cardiovascular diseases. , 2007, Sheng li xue bao : [Acta physiologica Sinica].
[30] P. Lazzerini,et al. Hyperhomocysteinemia, inflammation and autoimmunity. , 2007, Autoimmunity reviews.
[31] A. Whitehead,et al. Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus. , 2007, The Journal of rheumatology.
[32] J. Musial,et al. [Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus]. , 2007, Polskie Archiwum Medycyny Wewnetrznej.
[33] P. Raggi,et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors , 2006, Annals of the rheumatic diseases.
[34] A. Akdoğan,et al. Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients , 2007, Clinical Rheumatology.
[35] Chen-Kang Chang,et al. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus. , 2006, Rheumatology.
[36] R. Cron,et al. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. , 2006, Arthritis and rheumatism.
[37] T. Tso,et al. Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus , 2006, Lupus.
[38] A. Jenkins,et al. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus , 2006, Internal medicine journal.
[39] Chen-Kang Chang,et al. A positive correlation between homocysteine and brachial–ankle pulse wave velocity in patients with systemic lupus erythematosus , 2006, Clinical Rheumatology.
[40] R. Kimberly,et al. Genetics of susceptibility and severity in systemic lupus erythematosus , 2005, Current opinion in rheumatology.
[41] S. Lentz. Mechanisms of homocysteine‐induced atherothrombosis , 2005, Journal of thrombosis and haemostasis : JTH.
[42] A. Amoroso,et al. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. , 2005, Arthritis and rheumatism.
[43] C. Kallenberg,et al. Accelerated Atherosclerosis in Patients with Systemic Autoimmune Diseases , 2005, Annals of the New York Academy of Sciences.
[44] Xiaofeng Li,et al. [A clinical study of hyperhomocysteinemia in rheumatological diseases]. , 2005, Zhonghua nei ke za zhi.
[45] B. Tsao. Update on human systemic lupus erythematosus genetics , 2004, Current opinion in rheumatology.
[46] Z. Amoura,et al. Nucleosomes in the pathogenesis of systemic lupus erythematosus. , 2004, Rheumatic diseases clinics of North America.
[47] P. Lipsky,et al. Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. , 2004, Arthritis and rheumatism.
[48] P. Lipsky,et al. Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability. , 2004, Arthritis and rheumatism.
[49] M. Alarcón‐Riquelme,et al. The genetic basis of systemic lupus erythematosus--knowledge of today and thoughts for tomorrow. , 2004, Human molecular genetics.
[50] D. Fuchs,et al. Moderate hyperhomocysteinemia and immune activation. , 2004, Current pharmaceutical biotechnology.
[51] I. Bruce,et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. , 2003, Arthritis and rheumatism.
[52] E. Morand,et al. Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus? , 2003, Immunology and cell biology.
[53] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[54] M. E. Arberas,et al. Homocisteína plasmática en pacientes con lupus eritematoso sistémico , 2003 .
[55] C. Cho,et al. Acquired activated protein C resistance, high tissue factor expression, and hyper‐homocysteinemia in systemic lupus erythematosus , 2003, American journal of hematology.
[56] G. Ruiz-Irastorza,et al. [Plasma homocysteine levels in systemic lupus erythematosus]. , 2003, Medicina clinica.
[57] A. Hamsten,et al. Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease , 2002, Lupus.
[58] T. Refai,et al. Hyperhomocysteinaemia and Risk of Thrombosis in Systemic Lupus Erythematosus Patients , 2002, Clinical Rheumatology.
[59] C. Woo,et al. Increased Monocyte Adhesion to Aortic Endothelium in Rats With Hyperhomocysteinemia: Role of Chemokine and Adhesion Molecules , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[60] J. Harley,et al. The genetics of systemic lupus erythematosus: putting the pieces together , 2002, Genes and Immunity.
[61] B. Richardson,et al. Pathogenesis of lupus. , 2002, Arthritis and rheumatism.
[62] T. Cheng,et al. Elevated Homocysteine Levels in Patients with Raynaud’s Phenomenon Secondary to Systemic Lupus Erythematosus , 2002, Clinical Rheumatology.
[63] M. Meydani,et al. Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. , 2002, Atherosclerosis.
[64] A. Hamsten,et al. Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus , 2001, Circulation.
[65] T. Behrens,et al. Delineating the genetic basis of systemic lupus erythematosus. , 2001, Immunity.
[66] N. Sivasubramanian,et al. Homocysteine Induces Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Aortic Endothelial Cells: Implications for Vascular Disease , 2001, Circulation.
[67] K. Ihara,et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. , 2001, Rheumatology.
[68] L. Criswell,et al. The Fcgamma receptor IIIA-158F allele is a major risk factor for the development of lupus nephritis among Caucasians but not non-Caucasians. , 2001, Arthritis and rheumatism.
[69] W. Arend,et al. Physiology of cytokine pathways in rheumatoid arthritis. , 2001, Arthritis and rheumatism.
[70] M. Mamula,et al. Molecular mimicry and the role of B lymphocytes in the processing of autoantigens , 2000, Cellular and Molecular Life Sciences CMLS.
[71] E. Martı́n-Mola,et al. Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women. , 1999, Clinical biochemistry.
[72] H. Blom,et al. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis , 1999, Annals of the rheumatic diseases.
[73] P. D. de Groot,et al. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study. , 1998, The Journal of rheumatology.
[74] J. Loscalzo,et al. Homocysteine and atherothrombosis. , 1998, The New England journal of medicine.
[75] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[76] R. Schlegel,et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[77] B. Hultberg,et al. Plasma homocysteine in renal failure. , 1993, Clinical nephrology.
[78] W. Vermaak,et al. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. , 1993, The American journal of clinical nutrition.
[79] J. Hardin. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. , 1986, Arthritis and rheumatism.